These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 28123103)

  • 41. Chronic BMAA exposure combined with TDP-43 mutation elicits motor neuron dysfunction phenotypes in mice.
    Arnold FJ; Burns M; Chiu Y; Carvalho J; Nguyen AD; Ralph PC; La Spada AR; Bennett CL
    Neurobiol Aging; 2023 Jun; 126():44-57. PubMed ID: 36931113
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Β-N-Methylamino-L-Alanine (BMAA) Toxicity Is Gender and Exposure-Age Dependent in Rats.
    Scott LL; Downing TG
    Toxins (Basel); 2017 Dec; 10(1):. PubMed ID: 29280981
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Cyanotoxin 2,4-DAB Reduces Viability and Causes Behavioral and Molecular Dysfunctions Associated with Neurodegeneration in Larval Zebrafish.
    Martin RM; Bereman MS; Marsden KC
    Neurotox Res; 2022 Apr; 40(2):347-364. PubMed ID: 35029765
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Beta-methylamino-alanine (BMAA) injures hippocampal neurons in vivo.
    Buenz EJ; Howe CL
    Neurotoxicology; 2007 May; 28(3):702-4. PubMed ID: 17379313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
    Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
    Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An explanation for the changes in collagen in sporadic amyotrophic lateral sclerosis.
    Field NC; Caller TA; Stommel EW
    Med Hypotheses; 2011 Oct; 77(4):565-7. PubMed ID: 21745715
    [TBL] [Abstract][Full Text] [Related]  

  • 47. BMAA selectively injures motor neurons via AMPA/kainate receptor activation.
    Rao SD; Banack SA; Cox PA; Weiss JH
    Exp Neurol; 2006 Sep; 201(1):244-52. PubMed ID: 16764863
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Common molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosis.
    Gruzman A; Wood WL; Alpert E; Prasad MD; Miller RG; Rothstein JD; Bowser R; Hamilton R; Wood TD; Cleveland DW; Lingappa VR; Liu J
    Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12524-9. PubMed ID: 17636119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new zebrafish model produced by TILLING of SOD1-related amyotrophic lateral sclerosis replicates key features of the disease and represents a tool for in vivo therapeutic screening.
    Da Costa MM; Allen CE; Higginbottom A; Ramesh T; Shaw PJ; McDermott CJ
    Dis Model Mech; 2014 Jan; 7(1):73-81. PubMed ID: 24092880
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuroprotective effect of activity-dependent neurotrophic factor against toxicity from familial amyotrophic lateral sclerosis-linked mutant SOD1 in vitro and in vivo.
    Chiba T; Hashimoto Y; Tajima H; Yamada M; Kato R; Niikura T; Terashita K; Schulman H; Aiso S; Kita Y; Matsuoka M; Nishimoto I
    J Neurosci Res; 2004 Nov; 78(4):542-52. PubMed ID: 15478191
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The cyanobacterial neurotoxin β-N-methylamino-l-alanine (BMAA) induces neuronal and behavioral changes in honeybees.
    Okle O; Rath L; Galizia CG; Dietrich DR
    Toxicol Appl Pharmacol; 2013 Jul; 270(1):9-15. PubMed ID: 23591064
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration? The beta-N-methylamino-L-alanine (BMAA) paradigm.
    Papapetropoulos S
    Neurochem Int; 2007 Jun; 50(7-8):998-1003. PubMed ID: 17296249
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diatoms: a novel source for the neurotoxin BMAA in aquatic environments.
    Jiang L; Eriksson J; Lage S; Jonasson S; Shams S; Mehine M; Ilag LL; Rasmussen U
    PLoS One; 2014; 9(1):e84578. PubMed ID: 24392143
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease.
    Pablo J; Banack SA; Cox PA; Johnson TE; Papapetropoulos S; Bradley WG; Buck A; Mash DC
    Acta Neurol Scand; 2009 Oct; 120(4):216-25. PubMed ID: 19254284
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Does α-amino-β-methylaminopropionic acid (BMAA) play a role in neurodegeneration?
    Chiu AS; Gehringer MM; Welch JH; Neilan BA
    Int J Environ Res Public Health; 2011 Sep; 8(9):3728-46. PubMed ID: 22016712
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Na
    Petrozziello T; Boscia F; Tedeschi V; Pannaccione A; de Rosa V; Corvino A; Severino B; Annunziato L; Secondo A
    Cell Commun Signal; 2022 Jan; 20(1):8. PubMed ID: 35022040
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1
    Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M
    Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622
    [TBL] [Abstract][Full Text] [Related]  

  • 58. beta-Methylamino-L-alanine (BMAA) and amyotrophic lateral sclerosis-parkinsonism dementia of the western Pacific.
    Duncan MW
    Ann N Y Acad Sci; 1992 May; 648():161-8. PubMed ID: 1637043
    [No Abstract]   [Full Text] [Related]  

  • 59. Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam.
    Murch SJ; Cox PA; Banack SA; Steele JC; Sacks OW
    Acta Neurol Scand; 2004 Oct; 110(4):267-9. PubMed ID: 15355492
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ALS-linked mutant SOD1 proteins promote Aβ aggregates in ALS through direct interaction with Aβ.
    Jang JY; Cho H; Park HY; Rhim H; Kang S
    Biochem Biophys Res Commun; 2017 Nov; 493(1):697-707. PubMed ID: 28864422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.